Sero Surveillance

The Sero-surveillance program is being proposed for active case finding, testing, and contact tracing as reports indicate that SARS-CoV-2 causes asymptomatic infection. The population-based sero-epidemiological studies will help to determine the burden of COVID 19 infection at the community level, to monitor the trends in the transmission of SARS-CoV-2 infection and help generate evidence on the role of asymptomatic and mild infections in transmission. The outcomes will help in designing and implementing suitable Coronavirus containment measures. The sero-surveillance platform data would serve as a base to determine the sero-prevalence of SARS-CoV-2 infection in the local communities, and further would help monitor the trends of sero-prevalence for SARS-CoV-2 infection in the general population and high burden cities, determine the socio-demographic risk factors for SARS-CoV-2 infection, and delineate the geographical spread of the infection in the general population and hotspot cities.

1. To establish serial sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in the general population, India,
   Organisation- King Edward Memorial Hospital and Research Center, Pune
   The program is supporting one site under the NBM DBT DRIVEN program, the King Edward Memorial Hospital and Research Center, Pune, of the 5 sites in this program that are being managed by the National Biopharma Mission.

2. Community testing for Covid-19 prevalence in Mumbai
   Organisation- Translational Health Science and Technology Institute, Faridabad with Tata Institute for Fundamental Research and Kasturba Hospital, Mumbai
   The second investment in this space is for Translational Health Science and Technology Institute, Faridabad with Tata Institute for Fundamental Research and Kasturba Hospital, Mumbai for assays to be conducted on a sub-set of samples collected during a sero-surveillance study in Mumbai to inform about seropositivity.